TreeWAS – Variant ID: rs2288061

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
E89.0 Postprocedural hypothyroidism	0.000	0.950	0.050
C18.9 Colon, unspecified	0.023	0.977	0.000
C18 Malignant neoplasm of colon	0.022	0.978	0.000
C16 Malignant neoplasm of stomach	0.022	0.978	0.000
C15-C26 Malignant neoplasms of digestive organs	0.022	0.978	0.000
C16.0 Cardia	0.021	0.979	0.000
C18.2 Ascending colon	0.020	0.980	0.000
C18.5 Splenic flexure	0.020	0.980	0.000
C25 Malignant neoplasm of pancreas	0.020	0.980	0.000
C24 Malignant neoplasm of other and unspecified parts of biliary tract	0.020	0.980	0.000
C18.4 Transverse colon	0.020	0.980	0.000
C25.9 Pancreas, unspecified	0.019	0.981	0.000
C21 Malignant neoplasm of anus and anal canal	0.019	0.981	0.000
C16.1 Fundus of stomach	0.019	0.981	0.000
C24.1 Ampulla of Vater	0.019	0.981	0.000
C16.5 Lesser curvature of stomach, unspecified	0.018	0.982	0.000
G45.9 Transient cerebral ischaemic attack, unspecified	0.018	0.982	0.000
C23 Malignant neoplasm of gallbladder	0.018	0.982	0.000
C17 Malignant neoplasm of small intestine	0.017	0.983	0.000
C18.8 Overlapping lesion of colon	0.017	0.983	0.000
C22 Malignant neoplasm of liver and intrahepatic bile ducts	0.017	0.983	0.000
C21.1 Anal canal	0.017	0.983	0.000
C16.3 Pyloric antrum	0.017	0.983	0.000
C16.8 Overlapping lesion of stomach	0.016	0.984	0.000
C16.6 Greater curvature of stomach, unspecified	0.016	0.984	0.000
C16.4 Pylorus	0.016	0.984	0.000
C25.1 Body of pancreas	0.016	0.984	0.000
C16.2 Body of stomach	0.016	0.984	0.000
C22.0 Liver cell carcinoma	0.016	0.984	0.000
C24.9 Biliary tract, unspecified	0.015	0.984	0.000
C16.9 Stomach, unspecified	0.016	0.984	0.000
C21.0 Anus, unspecified	0.015	0.985	0.000
C17.0 Duodenum	0.015	0.985	0.000
C25.8 Overlapping lesion of pancreas	0.014	0.985	0.000
C25.7 Other parts of pancreas	0.014	0.985	0.000
C25.4 Endocrine pancreas	0.014	0.985	0.000
C25.2 Tail of pancreas	0.014	0.985	0.000
C24.8 Overlapping lesion of biliary tract	0.014	0.985	0.000
C25.0 Head of pancreas	0.014	0.986	0.000
C21.2 Cloacogenic zone	0.014	0.986	0.000
C17.9 Small intestine, unspecified	0.014	0.986	0.000
C21.8 Overlapping lesion of rectum, anus and anal canal	0.014	0.986	0.000
C25.3 Pancreatic duct	0.013	0.986	0.000
C19 Malignant neoplasm of rectosigmoid junction	0.014	0.986	0.000
C18.3 Hepatic flexure	0.013	0.987	0.000
C24.0 Extrahepatic bile duct	0.013	0.987	0.000
C18.1 Appendix	0.013	0.987	0.000
C18.0 Caecum	0.013	0.987	0.000
C17.8 Overlapping lesion of small intestine	0.013	0.987	0.000
C17.3 Meckel's diverticulum	0.013	0.987	0.000
C17.1 Jejunum	0.012	0.987	0.000
C22.7 Other specified carcinomas of liver	0.012	0.988	0.000
C22.4 Other sarcomas of liver	0.012	0.988	0.000
C22.3 Angiosarcoma of liver	0.012	0.988	0.000
C22.2 Hepatoblastoma	0.012	0.988	0.000
C26 Malignant neoplasm of other and ill-defined digestive organs	0.012	0.988	0.000
O32.1 Maternal care for breech presentation	0.000	0.989	0.011
C22.1 Intrahepatic bile duct carcinoma	0.011	0.989	0.000
G45 Transient cerebral ischaemic attacks and related syndromes	0.010	0.990	0.000
C17.2 Ileum	0.010	0.990	0.000
C18.7 Sigmoid colon	0.010	0.990	0.000
G45.8 Other transient cerebral ischaemic attacks and related syndromes	0.009	0.991	0.000
C26.9 Ill-defined sites within the digestive system	0.009	0.991	0.000
C26.8 Overlapping lesion of digestive system	0.009	0.991	0.000
C26.1 Spleen	0.009	0.991	0.000
G45.4 Transient global amnesia	0.009	0.991	0.000
E89 Postprocedural endocrine and metabolic disorders, not elsewhere classified	0.000	0.991	0.009
C22.9 Liver, unspecified	0.008	0.992	0.000
C18.6 Descending colon	0.008	0.992	0.000
M75.1 Rotator cuff syndrome	0.000	0.992	0.008
G45.1 Carotid artery syndrome (hemispheric)	0.008	0.992	0.000
C15 Malignant neoplasm of oesophagus	0.008	0.992	0.000
G45.2 Multiple and bilateral precerebral artery syndromes	0.008	0.992	0.000
I69.4 Sequelae of stroke, not specified as haemorrhage or infarction	0.000	0.993	0.007
G45.0 Vertebro-basilar artery syndrome	0.007	0.993	0.000
E89.9 Postprocedural endocrine and metabolic disorder, unspecified	0.000	0.993	0.006
E89.8 Other postprocedural endocrine and metabolic disorders	0.000	0.993	0.006
E89.5 Postprocedural testicular hypofunction	0.000	0.993	0.006
E89.4 Postprocedural ovarian failure	0.000	0.993	0.006
E89.1 Postprocedural hypoinsulinaemia	0.000	0.993	0.006
I69.8 Sequelae of other and unspecified cerebrovascular diseases	0.000	0.994	0.006
I69 Sequelae of cerebrovascular disease	0.000	0.994	0.006
E89.6 Postprocedural adrenocortical(-medullary) hypofunction	0.000	0.994	0.006
E89.3 Postprocedural hypopituitarism	0.000	0.994	0.006
C15.9 Oesophagus, unspecified	0.006	0.994	0.000
Z87.8 Personal history of other specified conditions	0.000	0.994	0.006
I67.8 Other specified cerebrovascular diseases	0.000	0.994	0.006
C15.8 Overlapping lesion of oesophagus	0.006	0.994	0.000
C15.2 Abdominal part of oesophagus	0.006	0.994	0.000
C15.1 Thoracic part of oesophagus	0.006	0.994	0.000
C15.0 Cervical part of oesophagus	0.006	0.994	0.000
R09.1 Pleurisy	0.000	0.994	0.006
T42.4 Benzodiazepines	0.006	0.994	0.000
R09.0 Asphyxia	0.000	0.994	0.006
I69.3 Sequelae of cerebral infarction	0.000	0.994	0.006
G45.3 Amaurosis fugax	0.005	0.994	0.000
I69.0 Sequelae of subarachnoid haemorrhage	0.000	0.995	0.005
R09 Other symptoms and signs involving the circulatory and respiratory systems	0.000	0.995	0.005
I61.2 Intracerebral haemorrhage in hemisphere, unspecified	0.005	0.995	0.000
G57.6 Lesion of plantar nerve	0.000	0.995	0.005
O32 Maternal care for known or suspected malpresentation of foetus	0.000	0.995	0.005
C15.3 Upper third of oesophagus	0.005	0.995	0.000
I61.9 Intracerebral haemorrhage, unspecified	0.005	0.995	0.000
C26.0 Intestinal tract, part unspecified	0.004	0.995	0.001
I67.2 Cerebral atherosclerosis	0.000	0.995	0.005
R09.8 Other specified symptoms and signs involving the circulatory and respiratory systems	0.000	0.995	0.005
I67 Other cerebrovascular diseases	0.000	0.995	0.005
I61 Intracerebral haemorrhage	0.005	0.995	0.000
C15.4 Middle third of oesophagus	0.005	0.995	0.000
D36.1 Peripheral nerves and autonomic nervous system	0.000	0.995	0.005
C91.1 Chronic lymphocytic leukaemia	0.005	0.995	0.000
M19.01 Primary arthrosis of other joints (Shoulder region)	0.000	0.995	0.005
O32.0 Maternal care for unstable lie	0.000	0.995	0.005
Z73.9 Problem related to life-management difficulty, unspecified	0.005	0.995	0.000
C20 Malignant neoplasm of rectum	0.005	0.995	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.005	0.995	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.005	0.995	0.000
R09.2 Respiratory arrest	0.000	0.995	0.005
I61.6 Intracerebral haemorrhage, multiple localised	0.004	0.995	0.000
I67.1 Cerebral aneurysm, nonruptured	0.000	0.995	0.005
I69.1 Sequelae of intracerebral haemorrhage	0.000	0.996	0.004
O32.5 Maternal care for multiple gestation with malpresentation of one foetus or more	0.000	0.996	0.004
I69.2 Sequelae of other nontraumatic intracranial haemorrhage	0.000	0.996	0.004
C91 Lymphoid leukaemia	0.004	0.996	0.000
I67.0 Dissection of cerebral arteries, nonruptured	0.000	0.996	0.004
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.004	0.996	0.000
I61.5 Intracerebral haemorrhage, intraventricular	0.004	0.996	0.000
I61.0 Intracerebral haemorrhage in hemisphere, subcortical	0.004	0.996	0.000
I61.1 Intracerebral haemorrhage in hemisphere, cortical	0.004	0.996	0.000
O32.2 Maternal care for transverse and oblique lie	0.000	0.996	0.004
O32.6 Maternal care for compound presentation	0.000	0.996	0.004
T43.5 Other and unspecified antipsychotics and neuroleptics	0.004	0.996	0.000
O32.4 Maternal care for high head at term	0.000	0.996	0.004
O32.3 Maternal care for face, brow and chin presentation	0.000	0.996	0.004
C91.9 Lymphoid leukaemia, unspecified	0.004	0.996	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.004	0.996	0.000
I67.7 Cerebral arteritis, not elsewhere classified	0.000	0.996	0.004
I67.6 Nonpyogenic thrombosis of intracranial venous system	0.000	0.996	0.004
I67.5 Moyamoya disease	0.000	0.996	0.004
I67.4 Hypertensive encephalopathy	0.000	0.996	0.004
I67.3 Progressive vascular leukoencephalopathy	0.000	0.996	0.004
C91.4 Hairy-cell leukaemia	0.004	0.996	0.000
I61.3 Intracerebral haemorrhage in brain stem	0.004	0.996	0.000
R09.3 Abnormal sputum	0.000	0.996	0.004
T42.0 Hydantoin derivatives	0.004	0.996	0.000
T42.1 Iminostilbenes	0.004	0.996	0.000
C91.5 Adult T-cell leukaemia	0.004	0.996	0.000
I61.8 Other intracerebral haemorrhage	0.003	0.996	0.000
E89.2 Postprocedural hypoparathyroidism	0.001	0.996	0.002
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.003	0.996	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.003	0.996	0.000
T42.3 Barbiturates	0.003	0.996	0.000
T42.2 Succinimides and oxazolidinediones	0.003	0.996	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.004	0.996	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.004	0.996	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.003	0.997	0.000
C91.8 Mature B-cell leukaemia Burkitt-type	0.003	0.997	0.000
C91.7 Other lymphoid leukaemia	0.003	0.997	0.000
C91.6 Prolymphocytic leukaemia of T-cell type	0.003	0.997	0.000
C91.3 Prolymphocytic leukaemia	0.003	0.997	0.000
C91.2 Subacute lymphocytic leukaemia	0.003	0.997	0.000
O32.8 Maternal care for other malpresentation of foetus	0.000	0.997	0.003
C92.0 Acute myeloid leukaemia	0.003	0.997	0.000
O32.9 Maternal care for malpresentation of foetus, unspecified	0.000	0.997	0.003
T43.9 Psychotropic drug, unspecified	0.003	0.997	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.003	0.997	0.000
T43.6 Psychostimulants with abuse potential	0.003	0.997	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.003	0.997	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.003	0.997	0.000
T43.2 Other and unspecified antidepressants	0.003	0.997	0.000
I61.4 Intracerebral haemorrhage in cerebellum	0.003	0.997	0.000
C92 Myeloid leukaemia	0.003	0.997	0.000
C92.7 Other myeloid leukaemia	0.003	0.997	0.000
M23.81 Other internal derangements of knee (Anterior cruciate ligament or Anterior horn of medial meniscus)	0.000	0.997	0.003
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.003	0.997	0.000
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue	0.003	0.997	0.000
K73.9 Chronic hepatitis, unspecified	0.003	0.997	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.003	0.997	0.000
L43.9 Lichen planus, unspecified	0.003	0.997	0.000
C93 Monocytic leukaemia	0.003	0.997	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.003	0.997	0.000
C93.1 Chronic monocytic leukaemia	0.003	0.997	0.000
C91.0 Acute lymphoblastic leukaemia	0.003	0.997	0.000
K85.1 Biliary acute pancreatitis	0.000	0.997	0.003
Z80.8 Family history of malignant neoplasm of other organs or systems	0.003	0.997	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.003	0.997	0.000
C88 Malignant immunoproliferative diseases	0.003	0.997	0.000
C86 Other specified types of T/NK-cell lymphoma	0.003	0.997	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.003	0.997	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.003	0.997	0.000
C85.7 Other specified types of non-Hodgkin's lymphoma	0.003	0.997	0.000
C82 Follicular [nodular] non-Hodgkin's lymphoma	0.003	0.997	0.000
T50.8 Diagnostic agents	0.003	0.997	0.000
C82.4 Follicular lymphoma grade IIIb	0.003	0.997	0.000
R59.1 Generalised enlarged lymph nodes	0.000	0.997	0.003
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.003	0.997	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.003	0.997	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.003	0.997	0.000
I67.9 Cerebrovascular disease, unspecified	0.000	0.997	0.003
C85 Other and unspecified types of non-Hodgkin's lymphoma	0.003	0.997	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.003	0.997	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.003	0.997	0.000
C88.0 Waldenstrom's macroglobulinaemia	0.003	0.997	0.000
K55.9 Vascular disorder of intestine, unspecified	0.000	0.997	0.003
N03.9 Unspecified	0.003	0.997	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.002	0.997	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.002	0.997	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.002	0.997	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.002	0.997	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.002	0.997	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.002	0.997	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.002	0.997	0.000
T44.0 Anticholinesterase agents	0.002	0.997	0.000
C82.1 Mixed small cleaved and large cell, follicular	0.003	0.997	0.000
C86.5 Angioimmunoblastic T-cell lymphoma	0.003	0.997	0.000
C82.7 Other types of follicular non-Hodgkin's lymphoma	0.003	0.997	0.000
C92.9 Myeloid leukaemia, unspecified	0.002	0.997	0.000
C92.8 Acute myeloid leukaemia with multilineage dysplasia	0.002	0.997	0.000
C92.6 Acute myeloid leukaemia with 11q23-abnormality	0.002	0.997	0.000
C92.5 Acute myelomonocytic leukaemia	0.002	0.997	0.000
C92.3 Myeloid sarcoma	0.002	0.997	0.000
C92.2 Subacute myeloid leukaemia	0.002	0.997	0.000
C81 Hodgkin's disease	0.003	0.997	0.000
T36 Poisoning by systemic antibiotics	0.003	0.997	0.000
C85.2 Mediastinal (thymic) large B-cell lymphoma	0.003	0.997	0.000
T50.7 Analeptics and opioid receptor antagonists	0.002	0.997	0.000
T50.5 Appetite depressants	0.002	0.997	0.000
T50.4 Drugs affecting uric acid metabolism	0.002	0.997	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.002	0.997	0.000
T50.1 Loop [high-ceiling] diuretics	0.002	0.997	0.000
T50.0 Mineralocorticoids and their antagonists	0.002	0.997	0.000
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.002	0.997	0.000
C94 Other leukaemias of specified cell type	0.002	0.997	0.000
C92.4 Acute promyelocytic leukaemia	0.002	0.997	0.000
M48.09 Spinal stenosis (Site unspecified)	0.000	0.997	0.003
T45.0 Antiallergic and antiemetic drugs	0.002	0.997	0.000
C95 Leukaemia of unspecified cell type	0.002	0.997	0.000
C93.9 Monocytic leukaemia, unspecified	0.002	0.997	0.000
C93.7 Other monocytic leukaemia	0.002	0.997	0.000
C93.3 Juvenile myelomonocytic leukaemia	0.002	0.997	0.000
C93.2 Subacute monocytic leukaemia	0.002	0.997	0.000
C93.0 Acute monocytic leukaemia	0.002	0.997	0.000
T45.2 Vitamins, not elsewhere classified	0.002	0.998	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.002	0.998	0.000
M75 Shoulder lesions	0.000	0.998	0.002
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.002	0.998	0.000
C86.6 Primary cutaneous CD30-positive T-cell proliferations	0.002	0.998	0.000
C86.4 Blastic NK-cell lymphoma	0.002	0.998	0.000
C86.3 Subcutaneous panniculitis-like T-cell lymphoma	0.002	0.998	0.000
C86.2 Enteropathy-type (intestinal) T-cell lymphoma	0.002	0.998	0.000
C86.1 Hepatosplenic T-cell lymphoma	0.002	0.998	0.000
C86.0 Extranodal NK/T-cell lymphoma, nasal type	0.002	0.998	0.000
C88.9 Malignant immunoproliferative disease, unspecified	0.002	0.998	0.000
C88.7 Other malignant immunoproliferative diseases	0.002	0.998	0.000
C88.3 Immunoproliferative small intestinal disease	0.002	0.998	0.000
C88.2 Gamma heavy chain disease	0.002	0.998	0.000
C88.1 Alpha heavy chain disease	0.002	0.998	0.000
M75.2 Bicipital tendinitis	0.000	0.998	0.002
T45.1 Antineoplastic and immunosuppressive drugs	0.002	0.998	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.002	0.998	0.000
T45.8 Other primarily systemic and haematological agents	0.002	0.998	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.002	0.998	0.000
T45.6 Fibrinolysis-affecting drugs	0.002	0.998	0.000
T45.4 Iron and its compounds	0.002	0.998	0.000
T45.3 Enzymes, not elsewhere classified	0.002	0.998	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.002	0.998	0.000
C82.6 Cutaneous follicle centre lymphoma	0.002	0.998	0.000
C82.5 Diffuse follicle centre lymphoma	0.002	0.998	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.002	0.998	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.002	0.998	0.000
T47.7 Emetics	0.002	0.998	0.000
T47.6 Antidiarrhoeal drugs	0.002	0.998	0.000
T47.5 Digestants	0.002	0.998	0.000
T47.4 Other laxatives	0.002	0.998	0.000
T47.3 Saline and osmotic laxatives	0.002	0.998	0.000
T47.2 Stimulant laxatives	0.002	0.998	0.000
T47.0 Histamine H(2)-receptor antagonists	0.002	0.998	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.002	0.998	0.000
C82.2 Large cell, follicular	0.002	0.998	0.000
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]	0.002	0.998	0.000
D17.3 Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites	0.002	0.998	0.000
C84 Peripheral and cutaneous T-cell lymphomas	0.002	0.998	0.000
C81.0 Lymphocytic predominance	0.002	0.998	0.000
C82.3 Follicular lymphoma grade IIIa	0.002	0.998	0.000
C85.0 Lymphosarcoma	0.002	0.998	0.000
M75.5 Bursitis of shoulder	0.000	0.998	0.002
T23.3 Burn of third degree of wrist and hand	0.002	0.998	0.000
T41.5 Therapeutic gases	0.002	0.998	0.000
T41.4 Anaesthetic, unspecified	0.002	0.998	0.000
T41.3 Local anaesthetics	0.002	0.998	0.000
T41.2 Other and unspecified general anaesthetics	0.002	0.998	0.000
T41.1 Intravenous anaesthetics	0.002	0.998	0.000
T41.0 Inhaled anaesthetics	0.002	0.998	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.002	0.998	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.002	0.998	0.000
T48.5 Anti-common-cold drugs	0.002	0.998	0.000
T48.4 Expectorants	0.002	0.998	0.000
T48.3 Antitussives	0.002	0.998	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.002	0.998	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.002	0.998	0.000
T48.0 Oxytocic drugs	0.002	0.998	0.000
T49.9 Topical agent, unspecified	0.002	0.998	0.000
T49.8 Other topical agents	0.002	0.998	0.000
T49.7 Dental drugs, topically applied	0.002	0.998	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.002	0.998	0.000
T49.5 Ophthalmological drugs and preparations	0.002	0.998	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.002	0.998	0.000
T49.3 Emollients, demulcents and protectants	0.002	0.998	0.000
T49.2 Local astringents and local detergents	0.002	0.998	0.000
T49.1 Antipruritics	0.002	0.998	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.002	0.998	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.002	0.998	0.000
T37.5 Antiviral drugs	0.002	0.998	0.000
T37.4 Anthelminthics	0.002	0.998	0.000
T37.3 Other antiprotozoal drugs	0.002	0.998	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.002	0.998	0.000
T37.1 Antimycobacterial drugs	0.002	0.998	0.000
T37.0 Sulphonamides	0.002	0.998	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.002	0.998	0.000
C81.9 Hodgkin's disease, unspecified	0.002	0.998	0.000
S02.60 Fracture of mandible (closed)	0.000	0.998	0.002
T37.8 Other specified systemic anti-infectives and antiparasitics	0.002	0.998	0.000
D12.8 Rectum	0.002	0.998	0.000
C81.7 Other Hodgkin's disease	0.002	0.998	0.000
C81.4 Lymphocyte-rich classical Hodgkin lymphoma	0.002	0.998	0.000
C81.3 Lymphocytic depletion	0.002	0.998	0.000
C82.0 Small cleaved cell, follicular	0.002	0.998	0.000
C94.7 Other specified leukaemias	0.002	0.998	0.000
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified	0.002	0.998	0.000
C94.5 Acute myelofibrosis	0.002	0.998	0.000
C94.4 Acute panmyelosis	0.002	0.998	0.000
C94.3 Mast cell leukaemia	0.002	0.998	0.000
C94.2 Acute megakaryoblastic leukaemia	0.002	0.998	0.000
C94.1 Chronic erythraemia	0.002	0.998	0.000
C94.0 Acute erythraemia and erythroleukaemia	0.002	0.998	0.000
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified	0.002	0.998	0.000
C96.8 Histiocytic sarcoma	0.002	0.998	0.000
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.002	0.998	0.000
C96.6 Unifocal Langerhans-cell histiocytosis	0.002	0.998	0.000
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis	0.002	0.998	0.000
C96.4 Sarcoma of dendritic cells (accessory cells)	0.002	0.998	0.000
C96.3 True histiocytic lymphoma	0.002	0.998	0.000
C96.2 Malignant mast cell tumour	0.002	0.998	0.000
C96.1 Malignant histiocytosis	0.002	0.998	0.000
C96.0 Letterer-Siwe disease	0.002	0.998	0.000
T36.9 Systemic antibiotic, unspecified	0.002	0.998	0.000
T36.8 Other systemic antibiotics	0.002	0.998	0.000
T36.7 Antifungal antibiotics, systemically used	0.002	0.998	0.000
T36.6 Rifamycins	0.002	0.998	0.000
T36.5 Aminoglycosides	0.002	0.998	0.000
T36.4 Tetracyclines	0.002	0.998	0.000
T36.3 Macrolides	0.002	0.998	0.000
T36.2 Chloramphenicol group	0.002	0.998	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.002	0.998	0.000
C81.2 Mixed cellularity	0.002	0.998	0.000
D12.4 Descending colon	0.002	0.998	0.000
N60.2 Fibroadenosis of breast	0.000	0.998	0.002
T46 Poisoning by agents primarily affecting the cardiovascular system	0.002	0.998	0.000
T40.4 Other synthetic narcotics	0.002	0.998	0.000
D36 Benign neoplasm of other and unspecified sites	0.000	0.998	0.002
C95.7 Other leukaemia of unspecified cell type	0.002	0.998	0.000
C95.2 Subacute leukaemia of unspecified cell type	0.002	0.998	0.000
C95.1 Chronic leukaemia of unspecified cell type	0.002	0.998	0.000
C95.0 Acute leukaemia of unspecified cell type	0.002	0.998	0.000
I63.3 Cerebral infarction due to thrombosis of cerebral arteries	0.000	0.998	0.002
D36.0 Lymph nodes	0.000	0.998	0.002
N11.9 Chronic tubulo-interstitial nephritis, unspecified	0.002	0.998	0.000
M84.13 Nonunion of fracture [pseudarthrosis] (Forearm)	0.000	0.998	0.002
K92.9 Disease of digestive system, unspecified	0.000	0.998	0.002
N90.5 Atrophy of vulva	0.002	0.998	0.000
T45.5 Anticoagulants	0.002	0.998	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.002	0.998	0.000
K73 Chronic hepatitis, not elsewhere classified	0.002	0.998	0.000
M75.8 Other shoulder lesions	0.000	0.998	0.002
T36.0 Penicillins	0.002	0.998	0.000
C83 Diffuse non-Hodgkin's lymphoma	0.002	0.998	0.000
K73.2 Chronic active hepatitis, not elsewhere classified	0.002	0.998	0.000
T38.9 Other and unspecified hormone antagonists	0.002	0.998	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.002	0.998	0.000
T38.7 Androgens and anabolic congeners	0.002	0.998	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.002	0.998	0.000
T38.5 Other oestrogens and progestogens	0.002	0.998	0.000
T38.4 Oral contraceptives	0.002	0.998	0.000
T38.2 Antithyroid drugs	0.002	0.998	0.000
T38.1 Thyroid hormones and substitutes	0.002	0.998	0.000
T38.0 Glucocorticoids and synthetic analogues	0.002	0.998	0.000
C15.5 Lower third of oesophagus	0.002	0.998	0.000
C83.3 Large cell (diffuse)	0.002	0.998	0.000
C95.9 Leukaemia, unspecified	0.002	0.998	0.000
T23 Burn and corrosion of wrist and hand	0.002	0.998	0.000
M75.4 Impingement syndrome of shoulder	0.000	0.998	0.002
C81.1 Nodular sclerosis	0.002	0.998	0.000
C84.9 Mature T/NK-cell lymphoma, unspecified	0.002	0.998	0.000
C84.8 Cutaneous T-cell lymphoma, unspecified	0.002	0.998	0.000
C84.7 Anaplastic large cell lymphoma, ALK-negative	0.002	0.998	0.000
C84.6 Anaplastic large cell lymphoma, ALK-positive	0.002	0.998	0.000
C84.3 Lymphoepithelioid lymphoma	0.002	0.998	0.000
C84.2 T-zone lymphoma	0.002	0.998	0.000
C84.1 Sezary's diease	0.002	0.998	0.000
N18.2 Chronic kidney disease, stage 2	0.002	0.998	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.002	0.998	0.000
T40.8 Lysergide [LSD]	0.002	0.998	0.000
T40.7 Cannabis (derivatives)	0.002	0.998	0.000
T40.5 Cocaine	0.002	0.998	0.000
T40.3 Methadone	0.002	0.998	0.000
T40.1 Heroin	0.002	0.998	0.000
T40.0 Opium	0.002	0.998	0.000
C84.4 Peripheral T-cell lymphoma	0.002	0.998	0.000
T24.2 Burn of second degree of hip and lower limb, except ankle and foot	0.002	0.998	0.000
T23.2 Burn of second degree of wrist and hand	0.002	0.998	0.000
M84.15 Nonunion of fracture [pseudarthrosis] (Pelvic region and thigh)	0.000	0.998	0.002
S32.40 Fracture of acetabulum (closed)	0.002	0.998	0.000
T24.3 Burn of third degree of hip and lower limb, except ankle and foot	0.002	0.998	0.000
C85.9 Non-Hodgkin's lymphoma, unspecified type	0.002	0.998	0.000
M75.9 Shoulder lesion, unspecified	0.000	0.998	0.002
M06.34 Rheumatoid nodule (Hand)	0.002	0.998	0.000
T23.1 Burn of first degree of wrist and hand	0.002	0.998	0.000
T24 Burn and corrosion of hip and lower limb, except ankle and foot	0.002	0.998	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.001	0.998	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.001	0.998	0.000
T46.7 Peripheral vasodilators	0.001	0.998	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.001	0.998	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.001	0.998	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.001	0.998	0.000
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified	0.002	0.998	0.000
C84.0 Mycosis fungoides	0.002	0.998	0.000
T21.2 Burn of second degree of trunk	0.002	0.998	0.000
Z30.5 Surveillance of (intra-uterine) contraceptive device	0.002	0.998	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.002	0.998	0.000
G47.8 Other sleep disorders	0.002	0.998	0.000
L71.9 Rosacea, unspecified	0.000	0.998	0.002
B16.9 Acute hepatitis B without delta-agent and without hepatic coma	0.002	0.998	0.000
C84.5 Other and unspecified T-cell lymphomas	0.002	0.998	0.000
I82.8 Embolism and thrombosis of other specified veins	0.000	0.998	0.002
K73.8 Other chronic hepatitis, not elsewhere classified	0.002	0.998	0.000
Z29.1 Prophylactic immunotherapy	0.000	0.998	0.002
C92.1 Chronic myeloid leukaemia	0.002	0.998	0.000
O63.0 Prolonged first stage (of labour)	0.000	0.998	0.002
C83.7 Burkitt's tumour	0.002	0.998	0.000
C83.6 Undifferentiated (diffuse)	0.002	0.998	0.000
C83.5 Lymphoblastic (diffuse)	0.002	0.998	0.000
C83.4 Immunoblastic (diffuse)	0.002	0.998	0.000
C83.2 Mixed small and large cell (diffuse)	0.002	0.998	0.000
K73.1 Chronic lobular hepatitis, not elsewhere classified	0.002	0.998	0.000
K73.0 Chronic persistent hepatitis, not elsewhere classified	0.002	0.998	0.000
T25 Burn and corrosion of ankle and foot	0.002	0.998	0.000
M75.81 Other shoulder lesions, right shoulder	0.000	0.998	0.001
C50.1 Central portion of breast	0.002	0.998	0.000
F10.0 Acute intoxication	0.002	0.998	0.000
T25.0 Burn of unspecified degree of ankle and foot	0.002	0.998	0.000
A41.1 Septicaemia due to other specified staphylococcus	0.002	0.998	0.000
K14.0 Glossitis	0.000	0.998	0.002
T23.7 Corrosion of third degree of wrist and hand	0.002	0.998	0.000
T23.6 Corrosion of second degree of wrist and hand	0.002	0.998	0.000
T23.5 Corrosion of first degree of wrist and hand	0.002	0.998	0.000
T23.4 Corrosion of unspecified degree of wrist and hand	0.002	0.998	0.000
D47.3 Essential (haemorrhagic) thrombocythaemia	0.000	0.998	0.002
I80.1 Phlebitis and thrombophlebitis of femoral vein	0.002	0.998	0.000
D36.7 Other specified sites	0.000	0.998	0.002
L43 Lichen planus	0.002	0.998	0.000
N03 Chronic nephritic syndrome	0.002	0.998	0.000
A41.5 Septicaemia due to other Gram-negative organisms	0.002	0.998	0.000
R93.5 Abnormal findings on diagnostic imaging of other abdominal regions, including retroperitoneum	0.000	0.998	0.002
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.001	0.998	0.000
Y91.9 Alcohol involvement, not otherwise specified	0.002	0.998	0.000
M84.1 Nonunion of fracture [pseudarthrosis]	0.000	0.998	0.002
T21 Burn and corrosion of trunk	0.002	0.998	0.000
T20-T25 Burns and corrosions of external body surface, specified by site	0.002	0.998	0.000
I25.5 Ischaemic cardiomyopathy	0.002	0.998	0.000
Z12.1 Special screening examination for neoplasm of intestinal tract	0.002	0.998	0.000
Z73 Problems related to life-management difficulty	0.002	0.998	0.000
M06.36 Rheumatoid nodule (Lower leg)	0.001	0.998	0.000
H20.1 Chronic iridocyclitis	0.002	0.998	0.000
N03.1 Focal and segmental glomerular lesions	0.001	0.998	0.000
T24.7 Corrosion of third degree of hip and lower limb, except ankle and foot	0.001	0.998	0.000
T24.6 Corrosion of second degree of hip and lower limb, except ankle and foot	0.001	0.998	0.000
T24.5 Corrosion of first degree of hip and lower limb, except ankle and foot	0.001	0.998	0.000
T24.4 Corrosion of unspecified degree of hip and lower limb, except ankle and foot	0.001	0.998	0.000
T24.1 Burn of first degree of hip and lower limb, except ankle and foot	0.001	0.998	0.000
T25.2 Burn of second degree of ankle and foot	0.001	0.998	0.000
Z80.4 Family history of malignant neoplasm of genital organs	0.002	0.998	0.000
D35.2 Pituitary gland	0.000	0.998	0.002
T25.3 Burn of third degree of ankle and foot	0.001	0.998	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.001	0.998	0.000
T40.2 Other opioids	0.002	0.998	0.000
D36.9 Benign neoplasm of unspecified site	0.000	0.998	0.001
K86.8 Other specified diseases of pancreas	0.002	0.998	0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.001	0.998	0.000
T39.4 Antirheumatics, not elsewhere classified	0.001	0.998	0.000
T39.2 Pyrazolone derivatives	0.001	0.998	0.000
T40.6 Other and unspecified narcotics	0.001	0.998	0.000
Z73.6 Limitation of activities due to disability	0.001	0.998	0.000
N18.5 Chronic kidney disease, stage 5	0.002	0.998	0.000
S06.60 Traumatic subarachnoid haemorrhage (without open intracranial wound)	0.001	0.998	0.000
G62.8 Other specified polyneuropathies	0.000	0.998	0.002
T46.1 Calcium-channel blockers	0.001	0.998	0.000
C90 Multiple myeloma and malignant plasma cell neoplasms	0.001	0.998	0.000
R91 Abnormal findings on diagnostic imaging of lung	0.000	0.998	0.002
M06.32 Rheumatoid nodule (Upper arm)	0.001	0.998	0.000
M23.24 Derangement of meniscus due to old tear or injury (Lateral collateral ligament or Anterior horn of lateral meniscus)	0.000	0.998	0.001

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations